On behalf of the more than 6 million Americans living with Alzheimer’s and their families, we enthusiastically welcome the positive topline data reported today on the CLARITY AD Phase 3 clinical trial of lecanemab. Read our full statement: https://t.co/PV7bz21FXv. #Progress (1/4)
So proud to support the @alzassociation in this important fight to #ENDALZ. It may look like I'm napping, but I'm actually listening to an important talk on Alzheimer's and dementia research. #CatsLoveScience
Thank you to the nearly 12,000 leaders in dementia research who joined us in Denver, USA and online for #AAIC21! Together, you have advanced science and provided hope to all those living with Alzheimer’s and all other dementia.
Breaking news: The FDA has approved Aducanumab, the first FDA-approved drug that delays decline due to Alzheimer’s. On behalf of those impacted by Alzheimer’s & all other dementia, we celebrate today’s historic decision.
More days of cognition = more days of life for someone with Alzheimer’s. Heart this tweet if you want a drug that could slow the progression of this disease to give your family more good days, more laughter, more memories, #MoreTime.
Calling all researchers! 🔬 Share your findings at #AAIC21, the largest and most influential meeting dedicated to advancing dementia science! In-person & virtual opportunities will be available. Abstract submission deadline is 1/25. https://t.co/YZdzDoYMW6 #ENDALZ
What a great opportunity for early-career researchers! ALL in Neurosciences are invited to participate. And who doesn't love a FREE Neuroscience conference?! #CatsLoveScience#Neurosciences#Neuro#Research#ENDALZ
We’re excited to announce that the first-ever AAIC Neuroscience Next will take place Nov. 9-10! Researchers are invited to attend this free, virtual event showcasing the work of neuroscience students & early career investigators. More information coming soon! #ENDALZ
Pets can help to #ENDALZ too! Love that so many furry 'sidekicks' are joining their human researchers at #AAIC20. @alzassociation doing an amazing job with this virtual conference!
Welcome to the first day of #AAIC20! We are glad you’re here. Let us know where you are joining from and view today’s virtual program here: https://t.co/Mbi52QRE6l
We just finished the first round of live sessions talks!! #AAIC2020 and Cleo is really excited to hear the next ones! (it's also her first time at a #AAIC20 conference) @alzassociation#catinscience
Don't be lazy like me. It's time to register for #AAIC20. Make your way to Amsterdam to join this global forum to advance dementia science. https://t.co/NhqmKEUHSD #ENDALZ#CatsLoveScience@ISTAART
Early registration for #AAIC20 is open for ISTAART members. Attend the largest forum to advance dementia science in Amsterdam! Members enjoy exclusive benefits at AAIC, including invitations to members-only events and discounted registration. https://t.co/BZ4YK9HeAA
“Where we are today compared to 20 years ago is night and day. There are more women entering research, mentoring, and building up other women scientists. This is game changing. I'm so proud to work with women who are leading the field.” -Our @HeatherAlz | #WomenInScience#ENDALZ